HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Veterinary Medicines
  • >CMDv
  • >Procedural guidance
  • >Post Marketing Procedures
  • >Variations
  • CMDv
    • About CMDv
    • Implementation of the VMP Regulation
    • COVID-19
    • BREXIT
    • Procedural Contact Points
    • Procedural guidance
      • General Information on Applications
      • Validation of Applications
      • Applications for Marketing Authorisation
      • Post Marketing Procedures
        • Variations
        • Renewals
        • Pharmacovigilance
      • CMDv Review Procedure and Referrals
      • Re-examination after DCP/VRA
      • SPC Harmonisation
      • ASMF
      • SPC, Labelling and Package leaflet
      • Miscellaneous
    • Questions & Answers
    • Publications
    • Union Product Database (UPD)
  • VMRI Product Index
  • National Contacts

 

Variations

Guidance documents on Variations - Regulation (EU) 2019/6

Variations not requiring assessment (VNRA)

Commission Implementing Regulation (EU) 2021/17 of 8 January 2021 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council

Best Practice Guide for variations not requiring assessment

Variations requiring assessment (VRA)

Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations

Best Practice Guide for variations requiring assessment

Not already listed variations

Procedural advice for requests for the classification of variations not already listed in Commission Implementing Regulation (EU) 2021/17 or EMA/CMDv guidance on the details of the classification of variations requiring assessment according to Article 62

Request form - Request for a recommendation on the classification of a not already listed variation

Worksharings

Best Practice Guide for worksharing

Letter of Intent

Questions and answers

Q&A - List for the submission of variations according to Regulation (EU) 2019/6

CMDh-CMDv Q&A – List for QP declaration

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. HMA and CMDh/v are in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed. In case you notice information that should be updated, please report this website link using the contact form.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/veterinary-medicines/cmdv/procedural-guidance/post-marketing-procedures/variations.html